# How to Qualify for Compounded Semaglutide: A Practical 2026 Guide
If you are researching compounded semaglutide, one of the first questions is simple: do I actually qualify? The good news is that the criteria are well defined and based on the same clinical standards used for FDA-approved GLP-1 weight-management medications. The honest part is that a number on a chart does not decide anything by itself. A licensed physician reviews your full health profile and makes the final call.
This guide walks through exactly what determines eligibility: the typical BMI thresholds, the weight-related conditions that lower them, the contraindications that rule treatment out, what information you provide, and how the telehealth medical review actually works. By the end, you will know where you likely stand and what the next step looks like.
Compounded medications are not FDA-approved as final products. The active pharmaceutical ingredient is FDA-registered. Compounded medications are prescribed by US-licensed physicians and prepared by state-licensed compounding pharmacies. This article is educational and is not medical advice. A licensed physician makes the final determination of eligibility. Individual results vary.
The short answer: the two main BMI pathways
Most reputable telehealth programs use the same clinical thresholds that apply to FDA-approved GLP-1 medications for weight management. There are two common pathways in.
Pathway 1: BMI of 30 or higher. A body mass index of 30 or above is classified as obesity. This is the standard threshold for weight-management treatment on its own, without any additional condition required.
Pathway 2: BMI of 27 or higher with a weight-related condition. A BMI between 27 and 30 is classified as overweight. If you also have at least one weight-related health condition, you can typically qualify at this lower threshold. Common qualifying conditions include high blood pressure, type 2 diabetes, prediabetes, high cholesterol, and obstructive sleep apnea.
If you are not sure of your BMI, you can estimate it in a few seconds with our BMI calculator. Keep in mind that BMI is a screening tool, not a perfect measure. It does not distinguish muscle from fat, so very muscular individuals may have a high BMI without excess body fat. This is one of several reasons a physician, not a calculator, makes the final eligibility decision.
A closer look at the BMI thresholds
| BMI range | Classification | Typical eligibility |
|---|---|---|
| Below 27 | Normal to overweight | Generally not eligible for GLP-1 weight management |
| 27 to 29.9 | Overweight | Eligible with at least one weight-related condition |
| 30 and above | Obesity | Eligible on BMI alone |
These ranges mirror the criteria established for FDA-approved GLP-1 medications, which is why they are widely used across telehealth programs. The reason the threshold drops to 27 when a weight-related condition is present is that the added health risk changes the risk-benefit calculation in favor of treatment. A physician confirms both your BMI and any qualifying conditions during the review.
What counts as a weight-related condition
If your BMI is in the 27 to 30 range, a single qualifying condition can open the door. The conditions most commonly recognized include:
You do not need several of these. One documented weight-related condition is generally enough to qualify at the lower BMI threshold. During the assessment, you report your conditions and any related diagnoses, and the physician factors them into the decision.
What can disqualify you: contraindications that matter
Eligibility is not only about meeting a threshold. Semaglutide is a powerful medication, and it is not appropriate for everyone. Some factors are firm contraindications, and others require careful physician judgment.
*Firm contraindications, where semaglutide is not prescribed:*
*Conditions that require careful review and may rule out treatment:*
This is not a complete list, and it is not a substitute for a medical evaluation. It is meant to show why the review exists. The physician weighs your complete history, not any single item in isolation, before deciding whether compounded semaglutide is safe and appropriate for you. For more on the safety side, see our deeper look at whether compounded semaglutide is safe in 2026.
What information you provide during the assessment
The medical assessment is designed to give the reviewing physician an accurate picture of your health. Expect to share:
Accuracy here is not paperwork for its own sake. The physician relies entirely on what you report to make a safe decision, so complete and honest answers protect you. If something is unclear, the physician may request more detail or recent lab values before deciding.
How the telehealth eligibility review actually works
The process is straightforward, and it is built so that a licensed physician, not an algorithm, makes the determination.
Step 1: Complete the 2-minute assessment. You answer the health questions online at /quiz. It takes about two minutes.
Step 2: A licensed physician reviews your responses. A US-licensed physician evaluates your BMI, conditions, medications, and history against clinical criteria and safety considerations. This is the step that decides eligibility.
Step 3: You receive a determination. Many programs return a decision within about one business day. If the physician needs more information, such as a recent lab value or clarification on your history, the review can take a little longer because thoroughness comes first.
Step 4: If appropriate, a prescription is issued. When the physician determines compounded semaglutide is appropriate, a prescription is sent to a state-licensed compounding pharmacy, which prepares your medication.
Step 5: Ongoing check-ins. Treatment is not a one-time event. Follow-up reviews let the physician monitor how you are doing and adjust as needed.
At no point does meeting a BMI threshold automatically produce a prescription. The physician can decline or pause treatment at any stage if something in your profile raises a safety concern. That is the system working as intended.
Why a physician makes the final call
It can be tempting to treat eligibility like a checklist: hit the BMI number, check a box, get the medication. Real medicine does not work that way, and that is a feature, not a bug.
Two people can have identical BMIs and very different appropriate treatments because of their medication lists, family histories, or other conditions. The physician review exists to catch exactly those differences. A licensed physician is responsible for confirming that the benefits outweigh the risks for you specifically, for choosing an appropriate starting approach, and for monitoring over time. This is also why legitimate telehealth providers never skip the medical review or prescribe based on a form alone.
Cost is a separate question from eligibility
Qualifying medically and deciding the medication fits your budget are two different things. Compounded semaglutide is generally paid out of pocket, because compounded medications are rarely covered by insurance. We cover the numbers in detail in our guides to compounded semaglutide cost in 2026 and whether insurance covers compounded GLP-1 medications. The short version is that for many people without strong weight-loss coverage, an all-in compounded cash price can be lower than a brand-name out-of-pocket cost, and an HSA or FSA may lower the net cost further.
What to do if you do not qualify
If the physician determines compounded semaglutide is not appropriate for you, that is not the end of the road. Depending on the reason, there may be other paths worth discussing with a healthcare provider, including lifestyle-based weight management, addressing an underlying condition first, or a different medication for which you are a better candidate. A determination that one medication is not right for you is a safety decision, and it is worth respecting.
The bottom line
You likely qualify for compounded semaglutide if your BMI is 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes, prediabetes, high cholesterol, or obstructive sleep apnea. You would not qualify if you have a personal or family history of medullary thyroid carcinoma or MEN 2, are pregnant or breastfeeding, or have certain other conditions that make the medication unsafe for you. BMI and conditions are the starting screen, but a US-licensed physician reviews your complete profile and makes the final determination.
The clearest way to find out where you stand is to complete the assessment. Start your 2-minute medical review at /quiz, and a licensed physician will evaluate whether compounded semaglutide is appropriate for you.
This article is for educational purposes only and is not medical advice. Compounded medications are not FDA-approved as final products. The active pharmaceutical ingredient is FDA-registered. A licensed physician makes the final determination of eligibility. Always consult a licensed healthcare provider about your individual situation. Individual results may vary.
Frequently Asked Questions
What BMI do you need to qualify for compounded semaglutide?
Most telehealth programs follow the same clinical thresholds used for FDA-approved GLP-1 weight-management medications. The typical starting point is a body mass index (BMI) of 30 or higher, which is classified as obesity. A BMI of 27 or higher can also qualify when you have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, prediabetes, high cholesterol, or obstructive sleep apnea. BMI is only the first screen, though. A licensed physician reviews your full health profile and makes the final determination about whether compounded semaglutide is appropriate for you.
Who does not qualify for compounded semaglutide?
Semaglutide is not appropriate for everyone. The most important contraindications are a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It is also not prescribed to people who are pregnant, trying to become pregnant, or breastfeeding. A prior serious allergic reaction to semaglutide or any GLP-1 medication is disqualifying. Other conditions, such as a history of pancreatitis, gallbladder disease, certain gastrointestinal disorders, or a history of an eating disorder, require careful physician review and may rule out treatment. The reviewing physician weighs your complete history before deciding.
Do I need a prescription to get compounded semaglutide?
Yes. Compounded semaglutide is a prescription medication and can only be prescribed by a US-licensed physician after a medical evaluation. Through a telehealth program, you complete a health assessment, and a licensed physician reviews your information to decide whether the medication is appropriate and safe for you. There is no legitimate way to obtain compounded semaglutide without a valid prescription from a licensed provider. Any source offering it without a medical review should be avoided.
How long does the eligibility review take?
The initial assessment usually takes about two minutes to complete online. After you submit it, a licensed physician reviews your responses. Many telehealth programs return an eligibility decision within one business day, though timing varies by provider and by whether the physician needs additional information, such as recent lab values or clarification on your medical history. If something in your profile needs follow-up, the review can take a little longer because the physician is being thorough about safety.
Can I qualify if I have type 2 diabetes or prediabetes?
Type 2 diabetes and prediabetes are weight-related conditions that can actually lower the BMI threshold for eligibility to 27 or higher, rather than disqualifying you. That said, if you take other diabetes medications, the reviewing physician needs to know, because GLP-1 medications can affect blood sugar and may require coordination with your other treatments. This is exactly why the medical review exists. Share your full medication list and conditions so the physician can make a safe determination and, when appropriate, advise coordinating with the provider who manages your diabetes.
Is compounded semaglutide the same as Ozempic or Wegovy?
Compounded semaglutide uses the same active ingredient, semaglutide, as the brand-name products Ozempic and Wegovy. The difference is that brand-name products are FDA-approved, mass-manufactured final products, while compounded semaglutide is prepared for an individual patient by a state-licensed compounding pharmacy and is not an FDA-approved final product. The active pharmaceutical ingredient used in compounding is FDA-registered. Eligibility criteria are generally similar because the underlying medication is the same, but a licensed physician always makes the final determination based on your individual health profile.
All Majesta Health medical content is clinically reviewed before publication by US-licensed physicians affiliated with our clinical infrastructure partner, MD Integrations (MDI). Reviewers hold active state medical licenses, are board-certified in primary care or obesity medicine, and specialize in GLP-1 receptor agonist therapy for chronic weight management. MDI is LegitScript certified and SOC 2 Type II accredited.
- US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
- Board-certified in primary care and obesity medicine
- Active state medical licensure required for every prescribing clinician
- Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
- Telehealth practice across all 50 US states and DC through the MD Integrations Medical Services Organization
- Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited, 503A and 503B compounding)